Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Harnessing Breakthroughs, Targeting Cures

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Harnessing Breakthroughs, Targeting Cures
Transcriptional and epigenetic control of tumor cells
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
The two faces of p53: Tumor suppressor and oncogene
Carol L. Prives
Columbia Univ., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)
Richard S. Finn
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Discussant
José Baselga
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
New lymphoma therapies based on functional and structural genomics
Louis M. Staudt
NCI-CCR, Bethesda, MD, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Diet and cancer: Status report in 2014
Walter C. Willett
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Tumor-specific immune activation: Immuno-oncology comes of age
Roger M. Perlmutter
Merck Research Laboratories, Rahway., NJ, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7